Mechanistic studies on Hsp90 inhibition by ansamycin derivatives
- PMID: 17662999
- DOI: 10.1016/j.jmb.2007.06.065
Mechanistic studies on Hsp90 inhibition by ansamycin derivatives
Abstract
Heat shock protein 90 (Hsp90) is a molecular chaperone that is required for the maturation and activation of a number of client proteins, many of which are involved in cancer development. The ansamycin family of natural products and their derivatives, such as geldanamycin (GA), are well-known inhibitors of the essential ATPase activity of Hsp90. Despite structural studies on the complexes of ansamycin derivatives with the ATPase domain of Hsp90, certain aspects of their inhibitory mechanism remain unresolved. For example, it is known that GA in solution exists in an extended conformation with a trans amide bond; however, it binds to Hsp90 in a significantly more compact conformation with a cis amide bond. GA and its derivatives have been shown to bind to Hsp90 with low micromolar affinity in vitro, in contrast to the low nanomolar anti-proliferative activity that these drugs exhibit in vivo. In addition, they show selectivity towards tumour cells. We have studied both the equilibrium binding, and the association and dissociation kinetics of GA derivative, 17-DMAG, and the fluorescently labelled analogue BDGA to both wild-type and mutant Hsp90. The mutants were made in order to test the hypothesis that conserved residues near the ATP-binding site may catalyse the trans-cis isomerisation of GA. Our results show that Hsp90 does not catalyse the trans-cis isomerisation of GA, and suggests that there is no isomerisation step before binding to Hsp90. Experiments with BDGA measured over a wide range of conditions, in the absence and in the presence of reducing agents, confirm recent studies that have suggested that the reduced dihydroquinone form of the drug binds to Hsp90 considerably more tightly than the non-reduced quinone species.
Similar articles
-
Dihydroquinone ansamycins: toward resolving the conflict between low in vitro affinity and high cellular potency of geldanamycin derivatives.Biochemistry. 2006 May 2;45(17):5678-85. doi: 10.1021/bi0524969. Biochemistry. 2006. PMID: 16634649
-
Design, synthesis, and biological evaluation of hydroquinone derivatives of 17-amino-17-demethoxygeldanamycin as potent, water-soluble inhibitors of Hsp90.J Med Chem. 2006 Jul 27;49(15):4606-15. doi: 10.1021/jm0603116. J Med Chem. 2006. PMID: 16854066
-
A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors.Nature. 2003 Sep 25;425(6956):407-10. doi: 10.1038/nature01913. Nature. 2003. PMID: 14508491
-
Geldanamycin and its anti-cancer activities.Cancer Lett. 2010 Apr 1;290(1):24-35. doi: 10.1016/j.canlet.2009.07.010. Epub 2009 Oct 21. Cancer Lett. 2010. PMID: 19850405 Review.
-
[Heat shock protein 90: novel target for cancer therapy].Ai Zheng. 2004 Aug;23(8):968-74. Ai Zheng. 2004. PMID: 15301726 Review. Chinese.
Cited by
-
Design, synthesis, and biological evaluation of conformationally constrained cis-amide Hsp90 inhibitors.Org Lett. 2009 Jun 4;11(11):2353-6. doi: 10.1021/ol900783m. Org Lett. 2009. PMID: 19435295 Free PMC article.
-
A cytosolic relay of heat shock proteins HSP70-1A and HSP90β monitors the folding trajectory of the serotonin transporter.J Biol Chem. 2014 Oct 17;289(42):28987-9000. doi: 10.1074/jbc.M114.595090. Epub 2014 Sep 8. J Biol Chem. 2014. PMID: 25202009 Free PMC article.
-
Thermodynamic Analysis of the Geldanamycin-Hsp90 Interaction in a Whole Cell Lysate Using a Mass Spectrometry-Based Proteomics Approach.J Am Soc Mass Spectrom. 2016 Oct;27(10):1670-6. doi: 10.1007/s13361-016-1457-2. Epub 2016 Aug 16. J Am Soc Mass Spectrom. 2016. PMID: 27530778
-
Drosophila as an In Vivo Model for Human Neurodegenerative Disease.Genetics. 2015 Oct;201(2):377-402. doi: 10.1534/genetics.115.179457. Genetics. 2015. PMID: 26447127 Free PMC article. Review.
-
Induced fit versus conformational selection: From rate constants to fluxes… and back to rate constants.Pharmacol Res Perspect. 2021 Oct;9(5):e00847. doi: 10.1002/prp2.847. Pharmacol Res Perspect. 2021. PMID: 34459109 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
